Trial Details
COMPLETEDBasic Information
| Clinical ID | c3508 |
|---|---|
| Identifier | NCT01940848 |
| Trial Title | Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome |
| Interventions | DRUG: STW5 (Iberogast, BAY98-7411)|DRUG: Placebo |
Participant Information
| Sponsor | Bayer |
|---|---|
| City | Baden-Wurttemberg |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2013-10-11 |
|---|---|
| Primary Completion Date | 2017-10-25 |
| Completion Date | 2017-10-25 |